A major bullish trend may start only above 8,600 – 8,500 level, which seems far considering the strong resistance of 8,400. One can also see selling pressure around 8300 -8250 range, as per the daily chart. A breach of 7,900 may dent the sentiment further that can take the index towards 7,600 levels.
CLICK HERE FOR DETAILED CHART VIEW
Aurobindo Pharma (AUROPHARMA): The absence of follow-up buying has resulted in a correction of over 25 per cent in the last two months. Now, the major support of Rs 700 has become resistance for the upward reversal. Although, the RSI (Relative Strength Index) is trading around over-sold region, the stock is unable to cross significant resistance level of Rs 660 as per the daily chart. The immediate support comes at Rs 570 levels, considering the 'Death Cross' of 50 DMA with 200 DMA.
CLICK HERE FOR DETAILED CHART VIEW
Divi's Laboratories (DIVISLAB): The stock witnessed extensive selling pressure above Rs 1750 level. The profit booking scenario may persist for some more time. That said, one can look for opportunities around current levels of Rs 1,550 considering strong support and an earlier breakout range of Rs 1,420 – 1,380. The medium-term trend remains highly optimistic with “Buy on correction” strategy for a rally above Rs 2,000 as per the technical formation on the weekly chart.
CLICK HERE FOR DETAILED CHART VIEW
Lupin Ltd (LUPIN): The stock is trading around the crucial support of Rs 720 on closing basis. A close below this can trigger a sell-off in coming sessions. The stock slipped below the 100 DMA around Rs 885 to hit Rs 700 levels. At this juncture, Lupin needs to see some buying comfort coming in around Rs 700 – Rs 720 that can regain momentum later on. Else, the stock can see selling pressure that can take it down further towards Rs 650 - Rs 640 levels, the technical chart.
CLICK HERE FOR DETAILED CHART VIEW